Acasti Pharma Inc. (ACST)
NASDAQ: ACST · Real-Time Price · USD
2.720
-0.030 (-1.09%)
Sep 18, 2024, 4:00 PM EDT - Market closed

Acasti Pharma Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jun '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Net Income
-11.45-12.85-42.43-9.82-19.68-25.51
Upgrade
Depreciation & Amortization
0.010.010.12-0.922.32
Upgrade
Other Amortization
----0.26-
Upgrade
Loss (Gain) From Sale of Assets
-0.07-0.06----
Upgrade
Asset Writedown & Restructuring Costs
0.040.0433.950.255.7-
Upgrade
Stock-Based Compensation
1.070.911.811.341.171.95
Upgrade
Other Operating Activities
-0.930.9-9.55-6.223.241.51
Upgrade
Change in Accounts Receivable
0.440.08-0.3-0.020.060.58
Upgrade
Change in Accounts Payable
0.71-1.650.41-2.39-6.7-3.39
Upgrade
Change in Other Net Operating Assets
0.50.290.07-0.380.7-0.41
Upgrade
Operating Cash Flow
-9.69-12.33-15.91-17.23-14.32-22.95
Upgrade
Capital Expenditures
-0.02-0.02-0.02--0.07-0.32
Upgrade
Sale of Property, Plant & Equipment
0.110.11----
Upgrade
Investment in Securities
-0.0213.17-3.52-9.798.46
Upgrade
Investing Cash Flow
0.090.113.15-3.52-9.868.14
Upgrade
Short-Term Debt Repaid
------1.56
Upgrade
Total Debt Repaid
------1.56
Upgrade
Net Debt Issued (Repaid)
------1.56
Upgrade
Issuance of Common Stock
7.367.360.3-59.6314.73
Upgrade
Other Financing Activities
-----0.140.01
Upgrade
Financing Cash Flow
7.367.360.3-59.4913.18
Upgrade
Foreign Exchange Rate Adjustments
0--0.010.151.39-1
Upgrade
Net Cash Flow
-2.24-4.87-2.46-20.636.7-2.63
Upgrade
Free Cash Flow
-9.71-12.36-15.93-17.23-14.39-23.27
Upgrade
Free Cash Flow Margin
-----7340.82%-
Upgrade
Free Cash Flow Per Share
-0.93-1.30-2.14-2.81-5.82-13.21
Upgrade
Levered Free Cash Flow
-5.58-7.4-9.06-4.57-7.81-18.48
Upgrade
Unlevered Free Cash Flow
-5.58-7.4-9.06-4.57-7.91-18.32
Upgrade
Change in Net Working Capital
-1.661.26-0.4-1.683.257
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.